Boaz Weinstein’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-150,000
Closed -$13K 1145
2022
Q3
$13K Hold
150,000
﹤0.01% 1002
2022
Q2
$14K Hold
150,000
﹤0.01% 1031
2022
Q1
$47K Buy
+150,000
New +$54.7K ﹤0.01% 874
2021
Q2
Sell
-100,200
Closed -$50K 586
2021
Q1
$50K Buy
+100,200
New +$58K ﹤0.01% 402

Other funds holding EQHA.WS

Boaz Weinstein's EQHA.WS Position: Q4 2022 in Review

Boaz Weinstein sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 150,000 shares — an estimated $13K sold.

Boaz Weinstein first reported a position in EQHA.WS in Q1 2021 and held it in 4 quarters. The position peaked at $50K in Q1 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Boaz Weinstein reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Boaz Weinstein sold 150,000 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $13K.
  • Boaz Weinstein first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q1 2021 and held it in 4 quarters.
  • Boaz Weinstein's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $50K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.